Morgan Stanley downgraded ProFrac Holding to Equal Weight from Overweight with a price target of $14, down from $18. The analyst is neutral into the Q3 report, seeing upside to second half EBITDA results and guidance, offset by risks to consensus free cash flow outlooks in that period.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACDC: